AR
Alexandria Real Estate Equities
Private EquityActiveAlexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry, is the largest owner and pre-eminent
44
Investments
12
Exits
—
AUM
27.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Alexandria Real Estate Equities.
Investment Thesis & Strategy
Alexandria Real Estate Equities is a real estate private equity firm that invests in various stages of companies within the life science and commercial real estate industries. They focus on being the landlord of choice for life science companies.
Investment Activity
Deals per year over the last 7 years
1
20120
20131
20141
20151
20162
20174
2018Portfolio Companies
Selected investments from their portfolio of 44 companies
I
Ionis Pharmaceuticals
Biotech · Growth, 0
R
Regeneron Pharmaceuticals
Biotech · Growth, 0
V
Vaxcyte
Biotech · Growth, 2018
L
Lyell Immunopharma
Biotech · Growth, 2018
N
Nkarta Therapeutics
Biotech · Growth, 2018
G
Gossamer Bio
Biotech · Growth, 2018
B
BridgeBio Pharma
Biotech · Growth, 2017
T
Turning Point Therapeutics
Biotech · Growth, 2017
C
CRISPR Therapeutics
Biotech · Growth, 2016
R
Revolution Medicines
Biotech · Growth, 2015
K
Kura Oncology
Biotech · Growth, 2014
B
Blueprint Medicines
Biotech · Growth, 2012
Frequently Asked Questions
Alexandria Real Estate Equities focuses on Series B, Series C+ stage investments.